Nurr1 downregulation is caused by CREB inactivation in a Parkinson’s disease mouse model

Potent synthetic and endogenous ligands for the adopted orphan nuclear receptor Nurr1

(2021) Yongwoo Jang et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Roflupram exerts neuroprotection via activation of CREB/PGC‐1α signalling in experimental models of Parkinson's disease

(2020) Jiahong Zhong et al.   BRITISH JOURNAL OF PHARMACOLOGY

Diagnosis and Treatment of Parkinson Disease

(2020) Melissa J. Armstrong et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

α-Synuclein Negatively Regulates Nurr1 Expression Through NF-κB-Related Mechanism

(2020) Congcong Jia et al.   Frontiers in Molecular Neuroscience

GSK-3β Contributes to Parkinsonian Dopaminergic Neuron Death: Evidence From Conditional Knockout Mice and Tideglusib

(2020) Junyu Li et al.   Frontiers in Molecular Neuroscience

Minocycline Protects against Rotenone-Induced Neurotoxicity Correlating with Upregulation of Nurr1 in a Parkinson’s Disease Rat Model

(2019) Congcong Sun et al.   Biomed Research International

Molecular Insights into NR4A2(Nurr1): an Emerging Target for Neuroprotective Therapy Against Neuroinflammation and Neuronal Cell Death

(2019) Md. Jakaria et al.   MOLECULAR NEUROBIOLOGY

Total glucosides of paeony (TGP) extracted from Radix Paeoniae Alba exerts neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the cAMP/PKA/CREB signaling pathway

(2019) Meizhu Zheng et al.   JOURNAL OF ETHNOPHARMACOLOGY

Toward neuroprotective treatments of Parkinson’s disease

(2017) Kwang-Soo Kim   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Emerging Roles of CREB-Regulated Transcription Coactivators in Brain Physiology and Pathology

(2017) Carlos A. Saura et al.   TRENDS IN NEUROSCIENCES

Nurr1-Based Therapies for Parkinson's Disease

(2016) Jie Dong et al.   CNS Neuroscience & Therapeutics

Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease

(2015) S.-M. Oh et al.   EMBO Molecular Medicine

NURR1 in Parkinson disease—from pathogenesis to therapeutic potential

(2013) Mickael Decressac et al.   Nature Reviews Neurology

 -Synuclein-Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons

(2012) M. Decressac et al.   Science Translational Medicine

Ultrastructural and transcriptional profiling of neuropathological misregulation of CREB function

(2010) L M Valor et al.   CELL DEATH AND DIFFERENTIATION

CREB: a multifaceted regulator of neuronal plasticity and protection

(2010) Kensuke Sakamoto et al.   JOURNAL OF NEUROCHEMISTRY

NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection

(2010) N. Volakakis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and α-synuclein inclusions

(2009) Claire Gibrat et al.   JOURNAL OF NEUROCHEMISTRY

Nurr1 Is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons

(2009) B. Kadkhodaei et al.   JOURNAL OF NEUROSCIENCE